EVH — Evolent Health Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapValue Trap

Annual cashflow statement for Evolent Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-334	-37.6	-19.2	-113	-61.6
Depreciation
Deferred Taxes
Non-Cash Items	313	30.5	44.5	125	78.1
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-55.3	-13.6	-58.5	100	-113
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities	-16.2	38.7	-11.6	143	18.8
Capital Expenditures	-31.8	-25	-47.5	-28.7	-24.9
Purchase of Fixed Assets
Other Investing Cash Flow Items	293	9.2	-212	-387	-38
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	261	-15.8	-259	-416	-62.9
Financing Cash Flow Items	-27.9	56	-92.7	-63.7	-42.5
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-11.9	-29.5	132	281	-0.565
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	233	-6.64	-140	8.3	-45